human leukocyte antigen

(redirected from HLA antigen)
Also found in: Medical, Encyclopedia.

human leukocyte antigen

n. Abbr. HLA
Any of various cell-surface antigens in humans that are products of the major histocompatibility complex and are used to type tissue, as to match donors with recipients for organ transplantation.

HLA

human leukocyte antigen: any of a complex of genetically determined antigens, occurring on the surface of almost every human cell, by which one person's cells can be distinguished from another's and histocompatibility established.
[1970–75]
References in periodicals archive ?
test kit for the determination of antibodies against 8 3000 pieces of the class i hla antigen specificity of individual antigens.
The association of HLA antigen and GVHD in allogeneic hemopoietic stem cell transplantation with histocompatible sibling donor: A single-center experience in Korea.
It is estimated by ELISA method and the patient's serum is added to microwell and they are already bound with HLA antigen reacts with antibody present in the serum.
Laboratory testing in this case revealed the patient to have antibody to Class I HLA antigen by Antigen Capture ELISA II but not to other platelet specific antigens.
Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype," International Journal of Cancer, vol.
Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells.
The quest to find similar markers has fuelled the suggestion that slipped upper femoral epiphysis (SUFE) may be linked to the presence of a specific HLA antigen.
Patients with a history of GD were significantly more likely to have the HLA antigen allele B39 than were control patients (16% vs.
We do know that the molecular structure of antigens from these particular foodborne bacteria mimic the HLA antigen.
Wagner of the University of Minnesota School of Medicine in Minneapolis is scheduled to report similarly encouraging results from 18 more cord blood transplants, most of them involving a single HLA antigen mismatch, in the August Blood.